Zobrazeno 1 - 10
of 1 063
pro vyhledávání: '"R. Land"'
Publikováno v:
Gynecologic Oncology Reports, Vol 22, Iss C, Pp 1-3 (2017)
Externí odkaz:
https://doaj.org/article/7ea0f5eae767441dbd58b3f70833b736
Publikováno v:
Chemical Engineering Transactions, Vol 24 (2011)
Abstract preview not available - see full-text PDF article.
Externí odkaz:
https://doaj.org/article/55a1ec3320574dff877d78bf7fde730c
Autor:
Brian C. Crist, Maria M. Bazakos, Tyler J. Hardcastle, Ida M. Hyvarinen, Matthew R. Land, Ashley L. Laughlin, Katie J. Marschke, Amanda C. Morton, Alex Norlander, JonTia A. Pegues, Marie Ragias, Haley L. Soshnick, Michael R. Tirman, Annie R. Xie
Publikováno v:
Indiana Law Review. 55:611-649
Autor:
Norman Wolmark, Joel L. Weissfeld, Stephanie R. Land, D. Lawrence Wickerham, Walter M. Cronin, Jane A. Cauley, Joseph P. Costantino, Reena S. Cecchini
Perspective on This Article from Body Mass Index and the Risk for Developing Invasive Breast Cancer among High-Risk Women in NSABP P-1 and STAR Breast Cancer Prevention Trials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26fcf0c31bdb3f02d39003b56fb1df91
https://doi.org/10.1158/1940-6207.22524974
https://doi.org/10.1158/1940-6207.22524974
Autor:
Norman Wolmark, Joel L. Weissfeld, Stephanie R. Land, D. Lawrence Wickerham, Walter M. Cronin, Jane A. Cauley, Joseph P. Costantino, Reena S. Cecchini
High body mass index (BMI) has been associated with an increased risk for breast cancer among postmenopausal women. However, the relationship between BMI and breast cancer risk in premenopausal women has remained unclear. Data from two large preventi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47debfe6ede9d29a47d40e0d0e332257
https://doi.org/10.1158/1940-6207.c.6544511
https://doi.org/10.1158/1940-6207.c.6544511
Autor:
Jill M. Siegfried, Jennifer R. Grandis, Rodney J. Landreneau, Marie Acquafondata, Rajiv Dhir, Diana E. Lenzner, Stephanie R. Land, Sanja Dacic, Laura P. Stabile
Purpose: Steroid hormones and growth factors affect lung cancer, and it is possible they act in concert to influence patient outcome.Experimental Design: Primary lung tumors and normal lung tissue were analyzed for expression and localization of estr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c0be0fa05e084519deed7e62c73cf36
https://doi.org/10.1158/1078-0432.c.6519629.v1
https://doi.org/10.1158/1078-0432.c.6519629.v1
PDF - 135K, Appendix providing analyses of alternative smoking variables and interactions. Table A1. Multivariable analysis results (p-values, hazard ratios and 95% confidence intervals) for alternative smoking history variables. Table A2. Hazard rat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dc3fbfd410e605fae35365173013366
https://doi.org/10.1158/1055-9965.22436656
https://doi.org/10.1158/1055-9965.22436656
Autor:
Graham W. Warren, Michael C. Fiore, Carolyn M. Dresler, Scott J. Leischow, Paul M. Cinciripini, Roy S. Herbst, Robert A. Schnoll, Linda P. Sarna, Sheila A. Prindiville, Thomas H. Brandon, Nancy A. Rigotti, Ellen R. Gritz, Sonia A. Duffy, Dorothy K. Hatsukami, Jamie S. Ostroff, Sandra A. Mitchell, Carol M. Moinpour, Benjamin A. Toll, Stephanie R. Land
There is strong evidence that cigarette smoking causes adverse outcomes in people with cancer. However, more research is needed regarding those effects and the effects of alternative tobacco products and of secondhand smoke, the effects of cessation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5990c4171cc7fe9ed0006ba1505a601
https://doi.org/10.1158/1078-0432.c.6526749
https://doi.org/10.1158/1078-0432.c.6526749
Autor:
Jill M. Siegfried, Austin M. Dulak, K. Jin Kim, The Minh Luong, Sanja Dacic, Stephanie R. Land, Jinling Yin, Jide Jin, Phouthone Keohavong, Mary E. Rothstein, Laura P. Stabile
The hepatocyte growth factor (HGF)/c-Met signaling pathway is involved in lung tumor growth and progression, and agents that target this pathway have clinical potential for lung cancer treatment. L2G7, a single potent anti-human HGF neutralizing mono
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1786ac6c6ef706348c753f3ad88b6f20
https://doi.org/10.1158/1535-7163.c.6531021.v1
https://doi.org/10.1158/1535-7163.c.6531021.v1
Autor:
Jill M. Siegfried, Austin M. Dulak, K. Jin Kim, The Minh Luong, Sanja Dacic, Stephanie R. Land, Jinling Yin, Jide Jin, Phouthone Keohavong, Mary E. Rothstein, Laura P. Stabile
Supplementary Fig. S1 from Therapeutic targeting of human hepatocyte growth factor with a single neutralizing monoclonal antibody reduces lung tumorigenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ed8a521336690c29916e7c40536c7f5
https://doi.org/10.1158/1535-7163.22482858.v1
https://doi.org/10.1158/1535-7163.22482858.v1